Cancer virotherapy medicine received the grant from European Commission in order to initiate the commercialization in the EU markets
European Commission awarded Latima with a grant for cancer virotherapy medicine commercialization in the EU markets within a framework of Horizon 2020 programme “Dedicated support to the biotechnology SMEs closing the gap from lab to market”.Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly 80 billion euros of funding available over 7 years (2014 to 2020) in addition to the private investment that this money will attract. It promises more breakthroughs,…
Source: RealWire